Kazer et al., 2024 - Google Patents
Primary nasal influenza infection rewires tissue-scale memory response dynamicsKazer et al., 2024
View PDF- Document ID
- 8637597797695667533
- Author
- Kazer S
- Match C
- Langan E
- Messou M
- LaSalle T
- O’Leary E
- Marbourg J
- Naughton K
- von Andrian U
- Ordovas-Montanes J
- Publication year
- Publication venue
- Immunity
External Links
Snippet
The nasal mucosa is often the initial site of respiratory viral infection, replication, and transmission. Understanding how infection shapes tissue-scale primary and memory responses is critical for designing mucosal therapeutics and vaccines. We generated a …
- 230000004044 response 0 title abstract description 87
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alsoussi et al. | SARS-CoV-2 Omicron boosting induces de novo B cell response in humans | |
Fallerini et al. | Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study | |
Turner et al. | SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses | |
Lee et al. | Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children | |
Unterman et al. | Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19 | |
Sumida et al. | Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells | |
Dugan et al. | Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets | |
Meckiff et al. | Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4+ T cells | |
Massoni-Badosa et al. | An atlas of cells in the human tonsil | |
Holwerda et al. | Determining the replication kinetics and cellular tropism of influenza D virus on primary well-differentiated human airway epithelial cells | |
Do et al. | Host transcription profile in nasal epithelium and whole blood of hospitalized children under 2 years of age with respiratory syncytial virus infection | |
Filbin et al. | Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients | |
Amoriello et al. | The TCR repertoire reconstitution in multiple sclerosis: comparing one-shot and continuous immunosuppressive therapies | |
Woon et al. | Acute experimental infection of bats and ferrets with Hendra virus: Insights into the early host response of the reservoir host and susceptible model species | |
Kazer et al. | Primary nasal influenza infection rewires tissue-scale memory response dynamics | |
Ivanova et al. | SARS-CoV-2 mRNA vaccine elicits a potent adaptive immune response in the absence of IFN-mediated inflammation observed in COVID-19 | |
Pekayvaz et al. | Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection | |
Pfaff et al. | Proteogenomics uncovers critical elements of host response in bovine soft palate epithelial cells following in vitro infection with foot-and-mouth disease virus | |
Wani et al. | Contrasting gene expression profiles of monocytes and lymphocytes from peste-des-petits-ruminants virus infected goats | |
Xiong et al. | Cytotoxic CD161− CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus | |
Kazer et al. | Primary nasal viral infection rewires the tissue-scale memory response | |
Hong et al. | IL-23 promotes a coordinated B cell germinal center program for class-switch recombination to IgG2b in BXD2 mice | |
Wilson et al. | The influenza B virus victoria and yamagata lineages display distinct cell tropism and infection-induced host gene expression in human nasal epithelial cell cultures | |
Sen et al. | Single-cell immunogenomic approach identified SARS-CoV-2 protective immune signatures in asymptomatic direct contacts of COVID-19 cases | |
Odak et al. | Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine |